Literature DB >> 26032380

Differential Diagnosis of Candida Species With Real-Time Polymerase Chain Reaction and Melting Temperature Analyses (RTPCR-MTA).

Binxue Zhang1, Mina Izadjoo1.   

Abstract

Genus Candida covers more than 50 species, half of which can cause infections in humans. Some of the Candida species exhibit drug resistance; therefore, there is an urgent need for rapid and accurate differentiation for rendering appropriate and effective management. Here, we report a new methodology employing real-time polymerase chain reaction (RTPCR) and melting temperature analyses (MTA) procedures. Fungal ribosomal internal transcribed spacer 2 (ITS2) has been confirmed with variable nucleotide sequences, which makes it possible to differentiate one species from another by checking their melting temperature following PCR amplification. The universal primers (panFg) covering entire ITS2 region, from 5.8S to 28S rRNA genes, were designed to differentially identify most Candida species with RTPCR-MTA procedure. Nucleic acids from five genomes of closely related Candida species, which were experimentally spiked into human blood, were extracted and amplified. PCR amplicons were called for melting temperature of Candida albicans (87.49°C), C. glabrata (86.85°C), C. krusei (90.24°C), C. parapsilosis (86.22°C), and C. tropicalis (86.08°C). The melting temperature of each amplicon was consistent and reproducible in three replicate experiments (SD ± 0.04-0.32). The new RTPCR-MTA methodology showed promise in differential diagnosis of closely related Candida species from environmental and clinical samples. Reprint &
Copyright © 2015 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26032380     DOI: 10.7205/MILMED-D-14-00294

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  1 in total

Review 1.  Recent Progress in the Diagnosis of Pathogenic Candida Species in Blood Culture.

Authors:  Pakpoom Phoompoung; Methee Chayakulkeeree
Journal:  Mycopathologia       Date:  2016-03-22       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.